Multi-Country Validation of SAMBA - A Novel Molecular Point-of- Care Test for HIV-1 Detection in Resource-Limited Setting
dc.contributor.author | Ondiek, J | |
dc.contributor.author | Namukaya, Z | |
dc.contributor.author | Mtapuri-Zinyowera, S | |
dc.contributor.author | Balkan, S | |
dc.contributor.author | Elbireer, A | |
dc.contributor.author | Ushiro Lumb, I | |
dc.contributor.author | Kiyaga, C | |
dc.contributor.author | Goel, N | |
dc.contributor.author | Ritchie, A | |
dc.contributor.author | Ncube, P | |
dc.contributor.author | Omuomu, K | |
dc.contributor.author | Ndiege, K | |
dc.contributor.author | Kekitiinwa, A | |
dc.contributor.author | Mangwanya, D | |
dc.contributor.author | Fowler, Mary G | |
dc.contributor.author | Nadala, L | |
dc.contributor.author | Lee, H | |
dc.date.accessioned | 2017-07-05T18:24:55Z | |
dc.date.available | 2017-07-05T18:24:55Z | |
dc.date.issued | 2017-06-09 | |
dc.date.submitted | 2017-06-26 | |
dc.identifier.citation | Multi-Country Validation of SAMBA - A Novel Molecular Point-of- Care Test for HIV-1 Detection in Resource-Limited Setting. 2017 J. Acquir. Immune Defic. Syndr. | en |
dc.identifier.issn | 1944-7884 | |
dc.identifier.pmid | 28604503 | |
dc.identifier.doi | 10.1097/QAI.0000000000001476 | |
dc.identifier.uri | http://hdl.handle.net/10144/618951 | |
dc.description.abstract | Early diagnosis of HIV-1 infection and the prompt initiation of antiretroviral therapy are critical to achieving a reduction in the morbidity and mortality of infected infants. The SAMBA HIV-1 Qual Whole Blood Test was developed specifically for early infant diagnosis and prevention of mother-to-child transmission programs implemented at the point-of-care in resource-limited settings. | |
dc.language.iso | en | en |
dc.publisher | Lippincott Williams & Wilkins | en |
dc.rights | Archived with thanks to Journal of Acquired Immune Deficiency Syndromes (1999) | en |
dc.title | Multi-Country Validation of SAMBA - A Novel Molecular Point-of- Care Test for HIV-1 Detection in Resource-Limited Setting | en |
dc.identifier.journal | Journal of Acquired Immune Deficiency Syndromes (1999) | en |
refterms.dateFOA | 2019-03-04T13:29:04Z | |
html.description.abstract | Early diagnosis of HIV-1 infection and the prompt initiation of antiretroviral therapy are critical to achieving a reduction in the morbidity and mortality of infected infants. The SAMBA HIV-1 Qual Whole Blood Test was developed specifically for early infant diagnosis and prevention of mother-to-child transmission programs implemented at the point-of-care in resource-limited settings. |